4//SEC Filing
Blaustein Marc 4
Accession 0001209191-21-055451
CIK 0001733257other
Filed
Sep 9, 8:00 PM ET
Accepted
Sep 10, 4:27 PM ET
Size
5.6 KB
Accession
0001209191-21-055451
Insider Transaction Report
Form 4
Blaustein Marc
Chief Operating Officer
Transactions
- Award
Employee Stock Option (right to buy)
2021-09-08+150,000→ 150,000 totalExercise: $15.56Exp: 2031-09-07→ Common Stock (150,000 underlying)
Footnotes (1)
- [F1]Twenty-five percent (25%) of the shares subject to the option vest on September 8, 2022, and the remaining shares subject to the option shall vest in thirty-six (36) equal monthly installments thereafter, subject to the Reporting Person continuing to provide service through each such date.
Documents
Issuer
Finch Therapeutics Group, Inc.
CIK 0001733257
Entity typeother
Related Parties
1- filerCIK 0001880032
Filing Metadata
- Form type
- 4
- Filed
- Sep 9, 8:00 PM ET
- Accepted
- Sep 10, 4:27 PM ET
- Size
- 5.6 KB